Axplora has been created through the merger of Farmabios, Novasep and PharmaZell. It is a CDMO service provider that offers sustainable and cutting-edge API goods and services. It has a strong and flexible manufacturing network for APIs and is a global leader in non-sterile and sterile steroids. It is also a leading supplier of specialty API products, including 5-ASA, UDCA, certain amino acids, high-potency substances and anti-cancer drugs. Axplora offers specialized technologies like HPAPIs, ADC bioconjugation, hazardous chemistry, steroids, industrial chromatography and flow chemistry. It delivers high-quality products on time and at scale.